Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
VPS51 pseudogene 10 is a pseudogene (i.e., a segment of DNA that resembles a gene but is non-functional and not transcribed into a protein-coding messenger RNA) that is homologous to the active gene VPS51, which encodes a component of the Golgi-associated retrograde protein (GARP) complex involved in vesicular transport[3][4]. VPS51P10 itself does not produce a protein product, is not a validated drug target, and has no known role in biological function or disease. Genomic annotation sources indicate no known protein product, associated function, or implication in therapeutic strategies for this pseudogene[3][4]. Key clarifications: - VPS51P10 is distinct from the protein-coding gene VPS51; only the latter is functionally active and associated with diseases like pontocerebellar hypoplasia[1][5][2]. - No evidence supports VPS51P10 as a target for drugs, a biomarker, or a functional receptor, enzyme, transporter, or other pharmaceutical target[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on VPS51 pseudogene 10 (VPS51P10).